.png?sfvrsn=723bceb4_0)
Resources
Available CCPM biobank research study resources and services
Investigators & Industry Partners
"Our partnerships will help drive the healthcare discoveries of tomorrow and realize the full potential of precision medicine. We so appreciate our patients who have consented to participate and without whom discovery would not be possible.”– Richard Zane, MD, UCHealth Chief Medical Officer and Chief Innovation Officer |
Access to Biobank Committee (ABC)
Request access to CCPM biobank research study resources.png?sfvrsn=2f3aceb4_0)
FAQs
Frequently asked questions from investigators
About the CCPM Biobank Research Study
Established in 2014 as a partnership between UCHealth and University of Colorado Anschutz, the biobank at the Colorado Center for Personalized Medicine (CCPM biobank) brings together multiple disciplines and institutions to uncover advancements in genomics that can improve diagnosis and treatment of disease and identify more tailored approaches to population health management. The CCPM biobank aims to be one of the largest academic medicine and clinical biospecimen repositories in the U.S.
To accelerate research and advance personalized medicine, CCPM collaborates with industry partners and investigators. These partnerships allow CCPM and CCPM biobank study participants to contribute to scientific discoveries and research conducted around the world.
The CCPM biobank is able to link biospecimens and genotype information with patient health information from electronic medical records in an enterprise data warehouse, Health Data Compass, to support a broad range of research, operational and clinical quality improvement agendas.
To learn more about how the CCPM biobank research study works, click here.
CCPM is partnering with Regeneron Genetics Center, a subsidiary of Regeneron Pharmaceuticals, to create a large-scale genomics database.
The database will have de-identified genetic and clinical information from biobank participants and will be used to support research and
discovery of genetic factors that could inform clinical care.
Any industry partnerships that help maintain CCPM operations must sign an agreement such that they will not use, willingly allow or cause to have such data used for any purpose other than the performance of its obligations under the agreement without the prior written consent of University of Colorado, CCPM.
All data provided through Access to Biobank Committee (ABC) processes is intended solely for research purposes. It is not validated for clinical decision-making, diagnostic use or therapeutic guidance. Users must not interpret or apply this information in any clinical context.
Request an edit to this webpage here.